Concepedia

Susan Bakke

SB

Statistics

Publications

11

Citations

1.7K

H-Index

11

Active since

1999

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health Clinical Center

Cardinal Glennon Children’s Medical Center

National Institutes of Health

Susan Bakke is an author at National Cancer Institute specializing in diabetes, rehabilitation, and clinical exercise.

Top concepts

Publications per year

1999–2011

11

Publications

11

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Victor Sandor, Susan Bakke, Robert W. Robey et al. · PubMed · 2002 · 509 citations

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

Richard Piekarz, Robert W. Robey, Victor Sandor et al. · Blood · 2001 · 446 citations · Full text

Phase I Trial and Pharmacokinetic Study of BMS-247550, an Epothilone B Analog, Administered Intravenously on a Daily Schedule for Five Days

Jame Abraham, Manish Agrawal, Susan Bakke et al. · Journal of Clinical Oncology · 2003 · 136 citations

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma

Jame Abraham, Susan Bakke, Ann Rutt et al. · Cancer · 2002 · 120 citations · Full text

A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine

Jame Abraham, Maureen Edgerly, Richard H. Wilson et al. · Clinical Cancer Research · 2009 · 117 citations · Full text

1–5 of 11